Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PPS announced the Grand Opening of a new wing at the Riverview site dedicated to the production of HPAPIs with low Occupational Exposure Levels.
read more
Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program.
read more
Thursday, September 05, 2019
Accelerated Enrollment Solutions (AES), a business unit of PPD, has acquired the clinical research site business of Bioclinica.
read more
Wednesday, January 17, 2018
Pharmaceutical Product Development and Quotient Sciences announced a new collaboration to accelerate pediatric drug development.
read more
Monday, September 07, 2020
PPD and LT have entered into a collaboration to expand and enhance lupus clinical research for PPD’s pharmaceutical and biotech customers.
read more
Wednesday, February 20, 2019
PPD and HLT of China have signed an exclusive agreement to develop a distinctive service offering for the China drug-development market delivering data science-driven clinical trials.
read more
PPD and Evidera have joined the Massachusetts Institute of Technology Center for Biomedical Innovation’s New Drug Development Paradigms initiative as a strategic partner.
read more
PPD and Acurian announced a new patient concierge service designed to make it easier for patients to participate in clinical trials and help pharmaceutical and biotechnology clients retain patients.
read more
Pharmaceutical Product Development announced that its existing owners, affiliates of Hellman & Friedman and affiliates of The Carlyle Group, entered into definitive agreements to recapitalize PPD and expand the company’s ownership to include two new ...
read more
Experts from Pharmaceutical Product Development, LLC (PPD) speaking at the 2013 Partnerships in Clinical Trials Conference in Orlando, Fla., will focus on innovative collaborations and real-time data and analysis solutions that drive cost and time ...
read more
Thursday, January 09, 2020
PPD has expanded its operations and leadership team in China to provide enhanced clinical development, laboratory, regulatory, site conduct, patient access and post-approval services for international and China-based biopharmaceutical companies.
read more
Wednesday, August 10, 2016
Pharmaceutical Product Development, LLC (PPD), a global contract research organization (CRO), has entered into an agreement to acquire Evidera, a provider of evidence-based solutions to demonstrate the real-world effectiveness and value of ...
read more
Thursday, September 10, 2015
Pharmaceutical Product Development has announced that Michael Gold, M.D., has joined PPD’s neuroscience team to serve as vice president of global product development, strengthening the company's ability to help biopharmaceutical clients manage the ...
read more
Thursday, November 15, 2012
Pharmaceutical Product Development, LLC (PPD) has signed a license agreement to use Tessella and Berry Consultants’ FACTSTM software to create a more flexible, intuitive approach for designing both adaptive and fixed trials.
read more
Tuesday, November 19, 2013
Clinical research associates earn top honors at PharmaTimes’ industry competition
WILMINGTON, N.C. (November 18, 2013) – Pharmaceutical Product Development, LLC (PPD) today announced that company clinical research associates (CRAs) earned ...
read more